Pediatric biliary calculus disease: clinical spectrum, predisposing factors, and management outcome revisited
Tóm tắt
Biliary calculus disease (BCD) is one of the most prevalent diseases and poses a significant burden to the health care system in adults. The prevalence of BCD in children and adolescents is about 0.1% and 0.6%, respectively. Although many factors have been attributed to BCD in children, exact etiopathogenesis is not clear. BCD has been extensively studied in adults, but not much literature is available in children. The current review was undertaken to study BCD in children focusing on the objectives like predisposing factors, various modes of presentation, and management outcome of BCD in children in the northern part of India. Out of 42 children, two children had a history of ceftriaxone therapy. Two underwent ileal resection. The mean reticulocyte count was 1.79%. None had G6PD deficiency or abnormal osmotic fragility test. Clinical presentation was right upper quadrant pain (n = 42, 100%), calculous cholecystitis (n = 8, 19.0%), and jaundice (n = 3, 7.14%). The majority (n = 26, 61.92%) were overweight. Only 16.6% (n = 7) children had normal body mass index (BMI), and 9.3% (n = 4) were obese. The mean BMI was 26.3 kg/m2. 85.5% of children frequently consume junk foods. The majority of calculi were GB calculi accounting for 92.8% (n = 39) whereas 7.1% (n = 3) children had CBD calculi. Thirty-five were managed by laparoscopic cholecystectomy, three were managed by non-operative management, and one was managed by open cholecystectomy; among the three cases of CBD calculi, two were managed by endoscopic retrograde cholangiopancreatography (ERCP), stenting, and CBD exploration and one was managed by ERCP sphincterotomy. Diet and overweight both appear to be important risk factors for pediatric BCD. Drug-induced calculi can be safely observed.
Tài liệu tham khảo
Kaechele V, Wabitsch M, Thiere D, Kessler A, Haenle M, Mayer H, et al. Prevalence of gallbladder stone disease in obese children and adolescents: influence of the degree of obesity, sex, and pubertal development. J Pediatr Gastroenterol Nutr. 2006;42(1):66–70.
Yoo E, Lee S. The prevalence and risk factors for gallstone disease. Clin Chem Lab Med. 2009;7:47.
Coran A, Caldamone A, Adzick N, Krummel T, Laberge J, Shamberger R. Pediatric surgery, 2-volume set. 7th ed. London: Elsevier Health Sciences; 2012. p. 1341–5.
Malhotra S. Epidemiological study of cholelithiasis among railroad workers in India with special reference to causation. Gut. 1968;9(3):290–5.
Abdullah UY, Jassim HM, Baig AA, Khorsheed RM, et al. Gallstones in patients with inherited hemolytic diseases. Int J Pharm Pharm Sci. 2015;7(7):9–15.
Schweizer P, Lenz M, Kirschner H. Pathogenesis and symptomatology of cholelithiasis in childhood. Digest Surg. 2000;17(5):459–67.
Holcomb GW Jr, O'Neill JA Jr, Holcomb GW 3rd. Cholecystitis, cholelithiasis and common duct stenosis in children and adolescents. Ann Surg. 1980;191(5):626.
Koebnick C, Smith N, Black M, Porter A, Richie B, Hudson S, et al. Pediatric obesity and gallstone disease. J Pediatr Gastroenterol Nutr. 2012;55(3):328–33.
Heida A, Koot B, vd Baan-Slootweg O, Pels Rijcken T, Seidell J, Makkes S, et al. Gallstone disease in severely obese children participating in a lifestyle intervention program: incidence and risk factors. Int J Obes. 2014;38(7):950–3.
Schaad U, Tschäppeler H, Lentze M. Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis J. 1986;5(6):708–9.
Holcomb G. Ashcraft’s pediatric surgery. 6th ed. Philadelphia: Elsevier Health Sciences; 2014. p. 599–601.
Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Int Med. 1993;119(10):1029–35.
Lippi G, Favaloro EJ, Franchini M. Haemolysis index for the screening of intravascular haemolysis: a novel diagnostic opportunity? Blood Transfusion. 2018;16(5):433.
Nkhoma E, Poole C, Vannappagari V, Hall S, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mole Dis. 2009;42(3):267–78.
Mohapatra R, Warang P, Ghosh K, Colah R. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye. Cytometry Part B Clin Cytom. 2016;90(3):279–84.
Hoffbrand AV, Moss PA. Essential haematology. 6th ed. London: Wiley; 2011. p. 76–8.
Clark VL, Kruse JA. Clinical methods: the history, physical, and laboratory examinations. Jama. 1990;264(21):2808–9.
Poddar U. Gallstone disease in children. Indian Pediatr. 2010;47(11):945–53.
Saadati S, Hekmatdoost A, Asadzadeh-aghdaei H, et al. Animal and vegetarian protein sources in relationship with the risk of biliary stone; a case-control study from Iranian adults. Res Square. 2020. https://doi.org/10.21203/rs.2.21589/v1.
Kotrotsios A, Tasis N, Angelis S, Apostolopoulos AP, Vlasis K, Papadopoulos V, et al. Dietary intake and cholelithiasis: a review. J Long Term Eff Med Implants. 2019;29(4).
Richards D, Heel R, Brogden R, Speight T, Avery G. Ceftriaxone: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1984;27(6):469–527.
Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge: in vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology. 1990;99(6):1772–8.
Lee SP, Lipsky BA, Teefey SA. Gallbladder sludge and antibiotics. Pediatr Infect Dis J. 1990;9(6):422–3.
Schaad U, Suter S, Gianella-Borradori A, Pfenninger J, Auckenthaler R, Bernath O, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. New England J Med. 1990;322(3):141–7.
Biner B, Öner N, Çeltik C, Bostancioğlu M, Tunçbilek N, Güzel A, et al. Ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound. 2006;34(5):217–22.
Schaad U, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet. 1988;332(8625):1411–3.
Newman K, Powell D, Holcomb G. The management of choledocholithiasis in children in the era of laparoscopic cholecystectomy. J Pediatr Surg. 1997;32(7):1116–9.
Al Talhi Y, Shirah B, Altowairqi M, Yousef Y. Laparoscopic cholecystectomy for cholelithiasis in children with sickle cell disease. Clin J Gastroenterol. 2017;10(4):320–6.
Zeidan MM, Pandian TK, Ibrahim KA, Moir CR, Ishitani MB, Zarroug AE. Laparoscopic cholecystectomy in the pediatric population: a single-center experience. Surg Laparosc Endosc Percutaneous Techniq. 2014;24(3):248–50.
Keil R, Drábek J, Lochmannová J, Šťovíček J, Koptová P, Wasserbauer M, et al. ERCP in infants, children, and adolescents—different roles of the methods in different age groups. PLOS One. 2019;14(1):e0210805.